| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/27/2005 | CN1646527A Medicaments containing BETAMIMETICS drugs and a novel anticholinesterase drug |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646519A N-oxyde of N-phenyl-2-pyrimidine-amine derivatives |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/27/2005 | CN1646164A Process for the preparation of a nutrient formulation |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646140A Use of a compound having the ability to release CO in preparation of pharmaceutical compositions for treatment of inflammation |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646126A Medicaments containing steroids and a novel anticholinesterase drug |
| 07/27/2005 | CN1646118A Pharmaceutical composition for preventing or treating respiratory disease |
| 07/27/2005 | CN1646110A Tolterodine salts |
| 07/27/2005 | CN1646108A Aerosol formulation for inhalation comprising a tiotropium salt |
| 07/27/2005 | CN1646107A A method for treating carrier particles and its use |
| 07/27/2005 | CN1646099A Powder formulations suitable for inhalation |
| 07/27/2005 | CN1646095A Inhalation kit comprisung inhalable powder of tiotropium |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1644210A Soft capsule for treating cough and preparation thereof |
| 07/27/2005 | CN1644199A Use of ampeloptin in preparation of antivirus medicines |
| 07/27/2005 | CN1212166C Safety shield system for prefilled syringes |
| 07/27/2005 | CN1212151C Capsule of cordyceps |
| 07/27/2005 | CN1212119C Organic compounds |
| 07/27/2005 | CN1212116C Sophorcarpidine alkaloid and decongestant compound medicine and its preparation |
| 07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
| 07/26/2005 | US6921824 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921757 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 07/26/2005 | US6921540 Hypotonic brines comprising mixtures of sodium, potassium, magnesium, calcium, chlorine and sulfates in water, used for prevention of inflammation of mucous membranes and for dissolving plugs in ears |
| 07/26/2005 | US6921527 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2133439C Compounds useful for treating allergic and inflammatory diseases |
| 07/21/2005 | WO2005065700A1 Life-prolonging agent comprising polished rice-origin components as the active ingredient |
| 07/21/2005 | WO2005065699A1 Isolated extract comprising saponins of a plant as therapeutic agent |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2004056866A8 Asthma susceptibility locus |
| 07/21/2005 | US20050159611 Process for producing shogaols and intermediates for the synthesis thereof |
| 07/21/2005 | US20050159492 Enhancing bioavailability of oral immediate release tablets for low solubility medicants; respiratory inflammatory disorders |
| 07/21/2005 | US20050159491 Cerebrovascular and cardiovascular diseases; hot water extracting danshen plant and chromatographic separation on polyamide column; high yield, low cost, quality |
| 07/21/2005 | US20050159477 Prepared by suspending pseudomonic acid in water and gradually adding calcium hydroxide to pH of 7.8-8.5, filtering, and lyophilizing frozen solution of calcium pseudomonate in water; stable topical pharmaceutical preparations |
| 07/21/2005 | US20050159476 Pharmaceutical composition for preventing or treating respiratory disease |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159461 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159450 Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 07/21/2005 | US20050159443 For example, N-[2,4-dichloro-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-N-methyl-2-[1-methyl-5-(3-methyl-4-nitro-benzoyl)-1H-pyrrol-2-yl]-acetamide; bradykinin receptor agonists; for treating disorders such as pain, inflammation, asthma and allergy |
| 07/21/2005 | US20050159441 Active ingredient and solvent can be stored separately until apparatus is used in a nebuliser; propellant-free; active ingredient is present in highly-concentrated form for storage purposes; inhalers |
| 07/21/2005 | US20050159437 Pharmaceutical agents |
| 07/21/2005 | US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 07/21/2005 | US20050159425 Inducing tolerance to an antigen by administering to patient a prostaglandin or agonist thereof, a phosphodiesterase inhibitor, and antigen or a derivative thereof; suppressing immune system or an inflammatory response; for example, use of misoprostol and rolipram; antiinflammatory agents, antiallergens |
| 07/21/2005 | US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | US20050159397 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 07/21/2005 | US20050159360 Improved bioavailability |
| 07/21/2005 | US20050158828 Preparing immunoglobulin dimer for use in prevention and treatment of B cell lymphoma and chronic lymphocytic leukemia; immunotherapeutics |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
| 07/21/2005 | US20050158387 Olopatadine formulations for topical administration |
| 07/21/2005 | US20050158290 Process for the preparation of a nutrient formulation |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | CA2552090A1 Disubstituted chalcone oximes as selective agonists of rar.gamma. retinoid receptors |
| 07/21/2005 | CA2551900A1 Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/20/2005 | EP1555267A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES |
| 07/20/2005 | EP1555031A1 Angiogenesis inducer |
| 07/20/2005 | EP1555028A1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 07/20/2005 | EP1555025A2 Use of dehydroepiandrosterone analogs for the treatment of asthma |
| 07/20/2005 | EP1554303A1 Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester |
| 07/20/2005 | EP1554275A2 Compounds |
| 07/20/2005 | EP1554268A1 Pyrazole inhibitors of the transforming growth factor |
| 07/20/2005 | EP1554264A2 Medicinal arylethanolamine compounds |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1553954A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/20/2005 | EP1553943A1 Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 07/20/2005 | EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/20/2005 | EP1553922A1 Salmeterol superfine formulation |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1472251B1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | CN1643382A A cytocapacity test |
| 07/20/2005 | CN1643140A Combination of a growth factor and a protease enzyme |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |